


Sitka Biopharma Revenue
Biotechnology Research • Metro Vancouver A, British Columbia, Canada • 1-10 Employees
Sitka Biopharma revenue & valuation
| Annual revenue | $4,000,000 |
| Revenue per employee | $4,000,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $12,800,000 |
| Total funding | $1,200,000 |
Key Contact at Sitka Biopharma
Hardik Bhargava
Vice President, Strategic Partnerships
Company overview
| Headquarters | 2405 Wesbrook Mall, 4th Floor, Vancouver, BC V6T1Z3, CA |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Biotechnology, Pharmaceuticals, Drug Delivery, Biopharmaceuticals, Cancer, Polymer, Bladder Cancer, Hyperbranched Polyglycerols (Hpg) |
| Founded | 2013 |
| Employees | 1-10 |
| Socials |
About Sitka Biopharma
Sitka Biopharma, a spin-off company of CDRD Ventures Inc., has developed a novel polymer platform technology that improves drug absorption for cancer treatments. Its lead candidate is a formulation that allows taxane drugs to adhere and penetrate into the bladder wall, enhancing treatment benefit for bladder cancer. Preclinical proof-of-concept has been established and the company’s near term goal is to gain regulatory approval to commence clinical trials.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Frequently asked questions
4.8
40,000 users



